Transplantation of Reconstructed Renal Allografts Following Ex-Vivo Partial Nephrectomy - Trial NCT05725421
Access comprehensive clinical trial information for NCT05725421 through Pure Global AI's free database. This phase not specified trial is sponsored by Case Comprehensive Cancer Center and is currently Not yet recruiting. The study focuses on Renal Cell Carcinoma. Target enrollment is 5 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Case Comprehensive Cancer Center
Timeline & Enrollment
N/A
Jul 01, 2023
Jul 01, 2024
Primary Outcome
Safety and Feasibility of Radical Nephrectomy for a Small Renal Mass,Safety and feasibility for Renal Transplant Participants Receiving a Reconstructed Donor Kidney
Summary
This study is designed to investigate a novel approach to offer more ESRD participants the
 benefits associated with renal transplantation by increasing the supply of available
 allografts
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05725421
Non-Device Trial